Impact of different model structure and prior distribution in continual reassessment method (Q5087922): Difference between revisions

@@ Property / describes a project that uses @@
+bcrm
@@ Property / describes a project that uses: bcrm / rank @@
+Normal rank
@@ Property / MaRDI profile type @@
+MaRDI publication profile
@@ Property / MaRDI profile type: MaRDI publication profile / rank @@
+Normal rank
@@ Property / full work available at URL @@
+https://doi.org/10.1080/03610918.2018.1476698
+Normal rank
@@ Property / OpenAlex ID @@
+W2890200610
@@ Property / OpenAlex ID: W2890200610 / rank @@
+Normal rank
@@ Property / cites work @@
+Optimal Bayesian-feasible dose escalation for cancer phase I trials
+Normal rank
@@ Property / cites work @@
+Sequential Designs for Phase I Clinical Trials with Late‐Onset Toxicities
+Normal rank
@@ Property / cites work @@
+A Curve‐Free Method for Phase I Clinical Trials
@@ Property / cites work: A Curve‐Free Method for Phase I Clinical Trials / rank @@
+Normal rank
@@ Property / cites work @@
+Bayesian model averaging: A tutorial. (with comments and a rejoinder).
+Normal rank
@@ Property / cites work @@
+Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
+Normal rank
@@ Property / cites work @@
+Group Sequential and Adaptive Designs – A Review of Basic Concepts and Points of Discussion
+Normal rank
@@ Property / cites work @@
+Bayesian Model Averaging Continual Reassessment Method in Phase I Clinical Trials
+Normal rank
@@ links / mardi / name / links / mardi / name @@
+Publication:5087922